Gene Therapy Recurrent Ovarian Cancer
Published on Mar 25 2010, in the categories: General info
As we all know by now, the ovarian cancer is one of the four global leaders in the death causes segment. It is an unfortunate fact that year by year almost fifty two thousand suffering women lose their lives due to various complications that are delivered by this particular disease.
The affected women population is even bigger, and the really negative aspect of all this is that the main apparition cause is similar to an equation with lots and lots of unknown factors. This is why the search for the proper treatment method is so behind. We can talk about risk factors, the light symptomatic states that affect slowly the healthy body but not enough so that it could show on the CT scan when the oncology specialist is presuming something is wrong and searches for additional problematic in the reproductive system.

The risk factors are emphasized firstly by previous cancerous affections. A history of cancerous diseases may be enough to set a clear diagnose, or to make the specialist physician look harder. Many women had suffered from a form or another of breast cancer, once in their lifetimes, and although it had been treated, the risk factor still remains. Some cell activity that affects the internal tissue which creates the malignant tumor lie still in the body and get triggered by an unknown factor later on in life, developing forms of cancer in various region, but most often we are talking about the reproductive system, the ovarian cancer.

Another factor is the gene factor. Women that have a first or even a second degree relative in their families that had long time ago encountered a cancerous affliction, have thirty percent more chances of acquiring themselves a cancerous form. And it does not really matter when the diseased cells activity affected, the breast, the colon, the intestinal tract; it seems that there is a higher chance of development in the ovarian region, on the channel that links the ovaries to the fallopian tubes.
There a tissue mass conglomerate is formed because of the imbalanced activity of the tissue cells that in a healthy body should replace the elder cells and take on their responsibilities, here they gather around the tissue with no particular purpose and form the tumor.
When this stage is reached, we can affirm that the tumor formation can have to separate path ways. It can evolve and develop in to a malignant cell when complications arrive and the whole chemo therapy is mandatory, or the surgical intervention, but this can leave some cranked cells that will eventually create cases of recurrent ovarian cancers; or the benign one, when surgery or a lighter chemo can be delivered without major health risks.
Gene therapy or the placement of healthy genes in the inner tissue is a theoretical form of treatment, which the medical staff is hoping to develop in the next years. It is said to deliver results up until the third stage of development.
The affected women population is even bigger, and the really negative aspect of all this is that the main apparition cause is similar to an equation with lots and lots of unknown factors. This is why the search for the proper treatment method is so behind. We can talk about risk factors, the light symptomatic states that affect slowly the healthy body but not enough so that it could show on the CT scan when the oncology specialist is presuming something is wrong and searches for additional problematic in the reproductive system.

The risk factors are emphasized firstly by previous cancerous affections. A history of cancerous diseases may be enough to set a clear diagnose, or to make the specialist physician look harder. Many women had suffered from a form or another of breast cancer, once in their lifetimes, and although it had been treated, the risk factor still remains. Some cell activity that affects the internal tissue which creates the malignant tumor lie still in the body and get triggered by an unknown factor later on in life, developing forms of cancer in various region, but most often we are talking about the reproductive system, the ovarian cancer.

Another factor is the gene factor. Women that have a first or even a second degree relative in their families that had long time ago encountered a cancerous affliction, have thirty percent more chances of acquiring themselves a cancerous form. And it does not really matter when the diseased cells activity affected, the breast, the colon, the intestinal tract; it seems that there is a higher chance of development in the ovarian region, on the channel that links the ovaries to the fallopian tubes.
There a tissue mass conglomerate is formed because of the imbalanced activity of the tissue cells that in a healthy body should replace the elder cells and take on their responsibilities, here they gather around the tissue with no particular purpose and form the tumor.
When this stage is reached, we can affirm that the tumor formation can have to separate path ways. It can evolve and develop in to a malignant cell when complications arrive and the whole chemo therapy is mandatory, or the surgical intervention, but this can leave some cranked cells that will eventually create cases of recurrent ovarian cancers; or the benign one, when surgery or a lighter chemo can be delivered without major health risks.
Gene therapy or the placement of healthy genes in the inner tissue is a theoretical form of treatment, which the medical staff is hoping to develop in the next years. It is said to deliver results up until the third stage of development.
If you liked this post, subscribe to our blog by filling your e-mail address below:
Want to add something? Post your comments